Stay updated on VIS649 Safety and Efficacy in IgA Nephropathy Clinical Trial
Sign up to get notified when there's something new on the VIS649 Safety and Efficacy in IgA Nephropathy Clinical Trial page.

Latest updates to the VIS649 Safety and Efficacy in IgA Nephropathy Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoNo Change Detected
- Check18 days agoChange DetectedThe study record shows updated metadata: the sponsor/links section and “last update” timing reflect a more recent posting (2026-04-24 and 2026-04-10/2026-04). Some study location entries have also changed by removing added ZIP+4 details, while the core study description and clinical components remain the same.SummaryDifference0.5%

- Check25 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

- Check54 days agoChange DetectedRevision: v3.5.0 was added and Revision: v3.4.3 was removed.SummaryDifference0.0%

- Check68 days agoChange DetectedRevision: v3.4.3 was added to the documentation and Revision: v3.4.2 was removed.SummaryDifference0.0%

- Check90 days agoChange DetectedRevision updated from v3.4.1 to v3.4.2, a minor backend/UI update that does not modify study details or results. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check97 days agoChange DetectedA new revision label 'Revision: v3.4.1' was added and the previous label 'Revision: v3.4.0' was removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to VIS649 Safety and Efficacy in IgA Nephropathy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the VIS649 Safety and Efficacy in IgA Nephropathy Clinical Trial page.